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 Abstract 
Gels are the preferable dosage forms for topical delivery of drugs in present days, but their use is not suitable for 
drugs with hydrophobic nature. In order to overcome the limitation of gels as a dosage form for hydrophobic drugs, an 
emulsion based approach is being used. When gels and emulsions are used in combined form the dosage form are referred 
as emulgel. The combination of hydrophilic cornified cells in hydrophobic intercellular material provides a barrier to both 
hydrophilic and hydrophobic substances. Polymer can function as emulsifiers and thickeners because the gelling capacity of 
these compounds allows the formulation of stable emulsions by decreasing surface as well as interfacial tension and 
increasing the viscosity of the aqueous phase. Various permeation enhancers can potentiate the effect, so emulgels can be 
used as better topical drug delivery systems over the conventional systems. The use of emulgels can be used as formulation 
system for analgesics and antifungal drugs. 
Keywords: Emulgels, Topical drug delivery, Gellified emulsion, Polymers, Emulsifier, Thickener. 
1. Introduction  
Topical drug delivery can be defined as the 
application of a drug containing formulation to the skin to 
directly treat cutaneous disorder. The topical drug delivery 
includes the use of topical agents like ointments, creams 
and lotions, but they are usually very sticky causing 
uneasiness to the patient on application. Moreover they also 
have less spreading coefficient and need to be applied with 
rubbing. They also exhibit the problem of stability. In order 
to overcome these problems, the use of transparent gels has 
increased both in cosmetics and in pharmaceutical 
preparations [1,2]. 
A gel is colloid that is typically 99% by weight 
liquid, which is immobilized by surface tension between it 
and a macromolecular network of gelatin fibers. Gels are 
created by entrapment of large amounts of aqueous or 
hydro alcoholic liquid in a network of colloidal solid 
particles. Gel formulations generally provide faster drug 
release as compared to ointments and creams. In spite of 
many advantages of gels a major limitation is their inability 
to deliver hydrophobic drugs. To overcome this limitation 
an emulsion based approach is being used so that a 
hydrophobic therapeutic moiety can be successfully 
incorporated and delivered through gels. When gels and 
emulsions are used in combined form the dosage forms are 
referred as emulgels. Emulsions possess acertain degree of 
elegance and are easily washed off from skin. They also 
have a high ability to penetrate the skin. Emulgels for 
dermatological use have several favorable properties such 
as being thixotropic, greaseless, easily spreadable, easily 
removable, emollient, non-staining, water-soluble, longer 
shelf life, bio-friendly, transparent &pleasing appearance 
[2,3]. The structure of emulgel has been shown in Fig. 1. 
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Fig. 1: Emulgel structure 
 
2. Physiology of skin 
The emulgel preparation is meant to be applied to 
the skin, so basic knowledge of the skin physiology is very 
important for designing emulgel. The skin of an average 
adult body covers a surface area approximately 2m
2 
and 
receives about one third of the blood circulating through the 
body. An average human skin surface has 40-70 hair 
follicles and 200-300sweat ducts per cm
2
of the skin. The 
pH of the skin varies from 4 to 5.6.Sweat and fatty acid 
secreted from sebum influence the pH of the skin surface. 
The skin can be considered to have four distinct layers of 
tissue namely non-viable epidermis, viable epidermis, 
viable dermis and subcutaneous connective tissue [2,4]. The 
cross section of skin has been depicted in Fig. 2. 
 
 
Fig. 2: Skin cross section 
 
2.1 Non-viable epidermis 
Stratum corneum is the outer most layer of skin, 
which is the actual physical barrier to the most substances 
that come in contact with the skin. The stratum corneum is 
10 to 20 cell layer thick over most of the body. Each cell is 
a flat, plate like structure; 34-44 μm long, 25-36 μm 
wide,0.5 to 0.20 μm thick with surface area of 750 to 1200 
μm stocked up to each other in form of bricks. Stratum 
corneum consists of lipid (5-15%) including phospholipids, 
glycosphingolipid, cholesterol sulphate and neutral lipid, 
protein (75-85%) which is mainly keratin. 
2.2 Viable epidermis 
This layer of the skin resides between the stratum 
corneum and the dermis and has a thickness ranging from 
50-100 μm. The structures of the cells in the viable 
epidermis are physiochemically similar to other living 
tissues. Cells are held together by tonofibrils. The density 
of this region is not much different than water. The water 
content is about 90%. 
2.3 Dermis 
Dermis lies just beneath the viable epidermis. It is 
a structural fibrin that consists of a matrix of loose 
connective tissue composed of fibrous protein embedded in 
an amphorphose ground substance. The thickness of dermis 
ranges from 2000 to 3000 μm. 
2.4 Subcutaneous connective tissue 
The subcutaneous tissue or hypodermis is 
composed of loose textured, white, fibrous connective 
tissue containing blood and lymph vessels, secretary pores 
of the sweat gland and cutaneous nerves. Most investigators 
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consider that the drug permeating through the skin enter the 
circulatory system before reaching the hypodermis, 
although the fatty tissue could serve as a depot of the drug. 
 
3. Factors affecting topical absorption of drug 
The factors that affect the topical absorption of 
drug are as follows [5,6]: 
3.1 Physiological factors 
 Skin thickness. 
 Lipid content. 
 Density of hair follicles. 
 Density of sweat glands. 
 Skin pH. 
 Blood flow. 
 Hydration of skin. 
 Inflammation of skin. 
3.2 Physiochemical factors 
 Partition coefficient. 
 Molecular weight (<400 dalton). 
 Degree of ionization (only unionized drugs gets absorbed 
well). 
 Effect of vehicles. 
 
4. Factors to be considered when choosing a 
topical preparation 
Following factors must be taken care of during 
selection of a topical dosage form [7,8]: 
 Effect of the vehicle e.g. an occlusive vehicle enhances 
penetration of the active ingredient and improves 
efficacy. The vehicle itself may have a cooling, drying, 
emollient, or protective action. 
 Match the type of preparation with the type of lesions. 
(e.g., avoid greasy ointments for acute weepy dermatitis). 
 Match the type of preparation with the site (e.g., gel or 
lotion for hairy areas). 
 Irritation or sensitization potential. 
 
5. Composition of emulgel preparation 
The formulation components of emulgel include 
five major things like aqueous phase, oily phase, 
emulsifiers, gelling agents and permeation enhancers 
[9,10]: 
5.1 Aqueous material 
This forms the aqueous phase of the emulsion. 
Commonly water and alcohol are used for this purpose. 
5.2 Oils 
These agents constitute the oily phase of the 
emulsion. For externally applied emulsions, mineral oils 
(with or without soft or hard paraffin), are widely used as 
the vehicle for the drug as well as occlusive material. 
Widely used oils in oral preparations are castor oil, fish 
liver oil, rachis oil, cottonseed oil, and maize oil. 
5.3 Emulsifiers 
Emulsifiers are used to promote emulsification and 
to control stability during the shelf life. Polyethylene glycol 
stearate, Sorbitan monooleate (Span 80), Polyoxyethylene 
sorbitan monooleate (Tween 80), Stearic acid and Sodium 
stearate can be used for this purpose. 
5.4 Gelling agent 
These are the agents that increase the consistency 
of any dosage form and act as thickening agent. Carbopol 
934, Carbopol 940 and HPMC 2910 are gelling agents used 
in the emulgels. 
5.5 Permeation/Penetration enhancers 
These are agents that partition into and interact 
with skin constituents to induce a temporary and reversible 
increase in skin permeability. They temporarily disrupt the 
skin barrier, fluidize the lipid channels between 
corneocytes, alter the partitioning of the drug into skin 
structures, or enhance delivery into skin. Clove oil and 
menthol can be used as the permeation enhancers. 
The ideal attributes of penetration enhancers are: 
• They should be non-toxic, non-irritating and non- 
allergenic. 
• They should work rapidly; the activity and duration of 
effect should be predictable as well as reproducible. 
• They should have no pharmacological activity within the 
body i.e. should not bind to receptor sites. 
• The penetration enhancers should work unidirectional i.e. 
should allow therapeutic agents into the body whilst 
preventing the loss of endogenous material from the body. 
• The penetration enhancers should be compatible with both 
excipients and drugs. 
• They should be cosmetically acceptable with an 
appropriate skin ‘feel’. 
5.5.1 Mechanism of permeation enhancers 
Permeation enhancers may act by one or more of 
the following three mechanisms: 
 Disruption of the highly ordered structure of stratum 
corneum lipid. 
 Interaction with intercellular protein. 
 Improved partition of the drug, co enhancer or solvent 
into the stratum corneum. 
The enhancers act by altering one of three 
pathways. The key to alter the polar pathway is to cause 
protein conformational change or solvent swelling. The 
fatty acid enhancers increase the fluidity of the lipid protein 
portion of the stratum corneum. Some enhancers act on 
both polar and non-polar pathway by altering the multi 
laminate pathway for penetration. Enhancers can increase 
the drug diffusivity through skin proteins. The type of 
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enhancer employed has a significant impact on the design 
and development of the product. 
5.5.2 Pathway of transdermal permeation 
Permeation can occur by diffusion via: 
 Transdermal permeation, through the stratum corneum. 
 Intercellular permeation, through the stratum corneum. 
 Transappendaged permeation, via the hair follicle, 
sebaceous and sweat glands. 
Most molecules penetrate through skin via 
intercellular micro route and therefore many enhancing 
techniques disrupt or bypass its elegant molecular 
architecture. 
 
6. Emulgel preparation 
Broadly speaking, the preparation of emulgel 
includes three steps [11]: 
Step1: Formulation of emulsion either O/W or W/O 
Step2: Formulation of gel base 
Step3: Incorporation of emulsion into gel base with 
continuous stirring 
Mohammad suggested a method for preparing 
emulgel. The gel in formulations is prepared by dispersing 
Carbopol 934 and Carbopol 940 in purified water with 
constant stirring at a moderate speed. pH is adjusted to 6-
6.5 using triethanolamine (TEA). The oil phase of the 
emulsion is prepared by dissolving Span 20 in light liquid 
paraffin while the aqueous phase is prepared by dissolving 
Tween 20 in purified water. Methyl and propyl paraben are 
dissolved in propylene glycol whereas drug is dissolved in 
ethanol followed by mixing of both solutions in the aqueous 
phase. Both the oily and aqueous phases are separately 
heated at 70
0
 to80
0
C; then the oily phase is added to the 
aqueous phase with continuous stirring and cooled to room 
temperature. Glutaraldehyde is added during mixing of gel 
and emulsion in ratio 1:1 to obtain the emulgel[12]. 
 
7. Characterization of emulgel 
The emulgel can be evaluated using several 
parameters like physical appearance, spreadability, 
extrudability study, globule size distribution, rheological 
study, swelling index, ex–vivo bioadhesive strength 
measurement, drug content determination, in-vitro release 
study, microbiological assay, skin irritation test, accelerated 
stability studies and drug release kinetic study [13-16]. 
7.1 Physical appearance 
The emulgel is inspected visually for colour, 
homogeneity, consistency and pH. The pH value of aqueous 
solution of emulgel is measured by a pH meter. 
7.2 Spreadability 
Spreadability is determined by an apparatus that 
consists of a wooden block, provided by a pulley at one 
end. A ground glass slide is fixed on this block. An excess 
of emulgel is sandwiched between this slide and another 
glass slide provided with the hook. A 1 Kg weight is placed 
on the top of the two slides for 5 minutes to expel air and to 
provide a uniform film of the emulgel between the slides. 
Excess of the emulgel is scrapped off from the edges. The 
top plate is then subjected to pull off 80 gm. With the help 
of string attached to the hook, the time (in seconds) 
required by the top slide to cover a distance of 7.5 cm is 
noted. A shorter interval indicates better spreadability.  
Spreadability is calculated by using the formula, 
S= M.L/T 
Where, S = spreadability, 
M = Weight tied to upper slide 
L = Length of glass slides 
T = Time taken to separate the slides apart 
7.3 Extrudability study 
It is a test to determine the force required to 
extrude the material from a lacquered aluminum collapsible 
tube. The test is based upon the quantity of emulgel 
extruded from the tube on application of weight in grams 
required to extrude at least 0.5cm ribbon of emulgel in 10 
seconds. More quantity extruded better is extrudability. 
Extrudability = Applied weight to extrude emulgel from 
tube (in gm) / Area (in cm
2
) 
7.4 Globule size distribution 
A 1.0 gm sample is dissolved in purified water and 
agitated to get homogeneous dispersion. Sample is injected 
to photocell of zeta sizer. Mean globule diameter and 
distribution is obtained. 
7.5 Rheological study 
The viscosity of the different emulgel formulations 
is determined at 25°C using a cone and plate viscometer 
with spindle; connected to a thermostatically controlled 
circulating water bath. 
7.6 Swelling index 
To determine the swelling index of emulgel, 1 gm 
of gel is taken on porous aluminium foil and then placed 
separately in a 50 ml beaker containing 10 ml 0.1 N NaOH. 
Then samples are removed from beakers at different time 
intervals and reweighed.  
Swelling index is calculated as follows: 
Swelling Index (SW) % = [(Wt – W0) / W0] × 100 
Where, (SW) % = Equilibrium percent swelling, 
W0 = Original weight of emulgel,  
Wt = Weight of emulgel after time t 
7.7 Ex–vivo bioadhesive strength measurement 
The fresh skin of shaven mice is cut into pieces 
and washed with 0.1N NaOH. Two pieces of skin are tied 
to the two glass slide separately. One of the glass slides is 
fixed on the wooden piece and other piece is tied with the 
balance on right hand side.1 gm of topical emulgel is placed 
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between the two slides containing skin pieces, and extra 
weight from the left pan is removed to sandwich the two 
pieces of skin and some pressure is applied to remove the 
presence of air. The balance is kept in this position for 
5minutes. Weight is added slowly at 200 mg/ min to the 
left-hand pan until the patch gets detached from the skin 
surface. The weight required to detach the emulgel from the 
skin surface indicates the bioadhesive strength. 
The bioadhesive strength is calculated by using 
formula: 
Bioadhesive Strength = Weight required (gm) /Area (cm
2
) 
7.8 Drug content determination 
Drug concentration in emulgel is measured by 
spectrophotometer. A known quantity of emulgel is 
dissolved in solvent (methanol); sonication is done if 
required. Absorbance is measured after suitable dilution in 
UV spectrophotometer. 
7.9 In-vitro release study 
Franz diffusion cell is used for the drug release 
studies. A fixed quantity of emulgel is applied onto the 
surface of egg membrane evenly. The egg membrane is 
clamped between the donor and the receptor chamber of 
diffusion cell. The receptor chamber is filled with freshly 
prepared phosphate buffer (pH 5.5) solution. The receptor 
chamber is stirred by a magnetic stirrer. The samples (1.0 
ml aliquots) are collected at suitable time interval and 
analyzed for drug content by UV visible spectrophotometer 
after appropriate dilutions. The cumulative amount of drug 
released across the egg membrane is determined as a 
function of time. 
7.10 Microbiological assay 
Ditch plate technique is used, which is meant for 
evaluation of bacteriostatic or fungistatic activity of a 
compound. It is mainly applied for semisolid formulations. 
Previously prepared Sabouraud’s agar dried plates are used. 
Three grams of the emulgel are placed in a ditch cut in the 
plate. Freshly prepared culture loops are streaked across the 
agar at a right angle from the ditch to the edge of the plate. 
After incubation for 18 to 24 hours at 25°C, the fungal 
growth is observed and the percentage inhibition is 
measured as follows. 
  % inhibition = L2 / L1 × 100 
Where, L1 = total length of the streaked culture 
             L2 =length of inhibition 
7.11 Skin irritation test 
0.5 gm sample of the emulgel is applied to each 
site (two sites per rabbit) by introduction under a double 
gauze layer to an area of skin approximately 1”x1” (2.54 x 
2.54 cm
2
). Animals are returned to their cages and remained 
as such for 24 hours. After a 24 hour exposure, the emulgel 
is removed. The test sites are wiped with tap water to 
remove any remaining residue and the animals are observed 
for any sign of irritation or rashes. 
7.12 Accelerated stability studies  
Stability studies are performed according to ICH 
guidelines. The emulgel formulations are stored in hot air 
oven at 37 ± 2
0
, 45 ± 2
0
 and 60 ± 2
0
C for a period of 3 
months. The samples are analyzed for drug content every 
two weeks by UV-Visible spectrophotometer. Stability 
study is carried out by measuring the change in drug 
concentration and pH of emulgel at regular intervals of 
time. 
7.13 Drug release kinetic study 
To analyze the mechanism of drug release from the 
emulgel, the release data are fitted to following equations: 
Zero order equation: Q = k0 t  
Where, Q is the amount of drug released at time t, and k0 is 
the zero order release rate. 
First order equation: In (100 – Q) = In 100 – k1 t  
Where, Q is the percent of drug release at time t, and k1 is 
the first order release rate constant. 
Higuchi’s equation: Q = k2√t  
Where, Q is the percent of drug release at time t, and K2 is 
the diffusion rate constant. 
 
8. Marketed preparation available as emulgel  
Marketed products which are commercially 
available in emulgel type of dosage form are listed in Table 
1 with their marketed name and manufacturer company 
name [2-20]. 
Table 1: Some marketed preparations of emulgel 
S. No. Product Name Drug Manufacturer 
1 Miconaz-Hemulgel Miconazole nitrate, Hydrocortisone Medical union Pharmaceuticals 
2 Excex gel Clindamycin, Adapalene Zee laboratories 
3 Lupigyl gel Metronidazole Lupin Pharma 
4 Avindo gel Azithromycin Cosme Pharma laboratories 
5 Zorotene gel Tezarotene Elder Pharmaceuticals 
6 Topinate gel Clobetasol propionate Systopic Pharma 
7 Clinagel Clindamycinphosphate  Allantoin Stiefel Pharma 
8 Pernox gel Benzoyl peroxide Cosme Remedies Ltd 
9 Voltarenemulgel Diclofenac diethyl ammonium Novartis Pharma 
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9. Merits of using emulgel 
Following are the benefits of using emulgel over 
conventional topical dosage forms [21]: 
9.1 Better stability 
Emulgel show better stability than other 
transdermal preparations, e.g.: powders are hygroscopic, 
creams show phase inversion on breaking and ointment 
shows rancidity due to oily phase. 
9.2 More loading capacity 
Emulgels have better loading capacity due to their 
vast network, while other novel approaches like niosomes 
and liposomes are of nanosize and have vesicular 
structures. So niosomes and liposomes cause leakage and 
have lesser entrapment efficiency. 
9.3 Ease of incorporating hydrophobic drugs 
Most of the hydrophobic drugs cannot be 
incorporated directly into gel because solubility acts as a 
barrier and problem arises during release of drug. Emulgel 
helps in incorporation of hydrophobic drugs into oil phase 
and then oily globules are dispersed in aqueous phase 
resulting in o/w emulsion. This o/w emulsion can be mixed 
into a gel base. 
9.4 Production feasibility 
The emulgel preparation method comprises of 
simple and short steps, which increase the feasibility of 
production. 
9.5 Low preparation cost 
No specialized instruments are needed for 
preparation of emulgel. Moreover materials used are easily 
available and cheaper. This reduces the overall production 
cost of emulgels. 
9.6 No intensive sonication 
Production of vesicular preparations (niosomes 
and liposomes) needs intensive sonication, which may 
result in drug degradation and leakage. But emulgels don’t 
require intensive sonication, so drug degradation problems 
can be overcome. 
9.7 Controlled drug release 
Emulgels can be used to prolong the effect of 
drugs with shorter half-life. 
9.8 Patient compliance 
They are less greasy and easy to apply. 
 
10. Conclusion 
Emulgels are a relatively newer class of dosage 
form created by entrapment of large amounts of aqueous or 
hydro alcoholic liquid in a network of colloidal solid 
particles. Emulgels have ahigher aqueous component which 
permits greater dissolution of drugs, and also permit easy 
migration of the drug through a vehicle that is essentially a 
liquid. So the gelling agent is in the water phase which 
converts a classical emulsion into an emulgel. In the recent 
years, emulgels are popular due to better patient 
compliance. Since emulgels possess an edge in terms of 
spreadability, adhesion, viscosity and extrusion, they will 
become a fair choice as topical drug delivery system and a 
solution for loading hydrophobic drugs in water soluble gel 
bases. 
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